Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
Advertise | AdChoices
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
Visit take2la's column >>

TAKE2LA

a citizen
Articles Posted: 33  Links Seeded: 835
Member Since: 6/2008  Last Seen: 5/14/2012

What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

26,000 Claims over AstraZeneca's Seroquel & links to Diabetes

Seeded on Wed Feb 3, 2010 4:25 PM EST
Read ArticleArticle Source: Bloomberg.com
health, today, mental-health, wall-street, crimes, psychiatry, pharma, abuses, conflicts-of-interest
Seeded by take2la
Advertise | AdChoices

AstraZeneca is facing as many as 26,000 lawsuits over its antipsychotic drug Seroquel as the drugmaker prepares for its first jury trial over claims the medicine causes diabetes, according to court filings.

  • Enjoy this article? Help vote it up the 'Vine.

Published to:

  • take2la's Column, All of Newsvine
  • Groups: Mental Health and Wellness
  • Regions: none
  • Public Discussion (2)
take2la

AstraZeneca’s stock fell last week after the drugmaker’s sales forecast and stock-buyback plan disappointed some analysts and fourth-quarter profit missed estimates. The company plans to buy back as much as $1 billion of shares this year, officials said Jan. 28.

The company said in a U.S. Securities and Exchange Commission filing last week it faces more than 25,000 claims that Seroquel caused diabetes. That’s a 65 percent increase in cases over the number the company reported in a January 2009 regulatory filing. Many of the suits also claim AstraZeneca promoted Seroquel, approved for schizophrenic and bipolar patients, for unapproved uses.

"Seroquel, which generated sales of $4.9 billion last year, is AstraZeneca’s second-biggest seller after the ulcer treatment Nexium."

  • 1 vote
Reply#1 - Wed Feb 3, 2010 4:30 PM EST
take2la

Next stop--Coca Cola & the promoters of High Fructose Corn Syrup.

    Reply#2 - Sun Feb 28, 2010 11:22 AM EST
    Leave a Comment:
    You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
    You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
    (XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
    Newsvine Privacy Statement
    As a new user, you may notice a few temporary content restrictions. Click here for more info.
    FUN STUFF:
    • Leaderboard |
    • E-Mail Alerts |
    • Top of the Vine |
    • Newsvine Live |
    • Newsvine Archives |
    • The Greenhouse |
    COMPANY STUFF:
    • Code of Honor |
    • Company Info |
    • Contact Us |
    • Jobs |
    • User Agreement |
    • Privacy Policy |
    • About our ads
    LEGAL STUFF:
    • © 2005-2012 Newsvine, Inc. |
    • Newsvine® is a registered trademark of Newsvine, Inc. |
    • Newsvine is a property of msnbc.com